These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 19347014)

  • 1. Intestinal fibrosis in IBD--a dynamic, multifactorial process.
    Rieder F; Fiocchi C
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):228-35. PubMed ID: 19347014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.
    Bettenworth D; Rieder F
    Dig Dis; 2017; 35(1-2):25-31. PubMed ID: 28147352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease.
    Stewart DC; Berrie D; Li J; Liu X; Rickerson C; Mkoji D; Iqbal A; Tan S; Doty AL; Glover SC; Simmons CS
    PLoS One; 2018; 13(7):e0200377. PubMed ID: 29995938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of tissue remodeling in inflammatory bowel disease.
    Rieder F; Fiocchi C
    Dig Dis; 2013; 31(2):186-93. PubMed ID: 24030223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation accelerating intestinal fibrosis: from mechanism to clinic.
    Xin S; Liu X; He C; Gao H; Wang B; Hua R; Gao L; Shang H; Sun F; Xu J
    Eur J Med Res; 2024 Jun; 29(1):335. PubMed ID: 38890719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of non-inflammatory factors in intestinal fibrosis.
    Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR
    J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Lovisa S; Genovese G; Danese S
    J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic modulation during intestinal fibrosis.
    Bos S; Laukens D
    J Dig Dis; 2020 Jun; 21(6):319-325. PubMed ID: 32406133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the mechanisms of fibrosis in IBD?
    Lund PK; Rigby RJ
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S127-8. PubMed ID: 18816738
    [No Abstract]   [Full Text] [Related]  

  • 11. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Fraction from Lysate of a High Concentration Multi-Strain Probiotic Formulation Inhibits TGF-β1-Induced Intestinal Fibrosis on CCD-18Co Cells.
    Lombardi F; Augello FR; Palumbo P; Mollsi E; Giuliani M; Cimini AM; Cifone MG; Cinque B
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.
    Rieder F; Kessler S; Sans M; Fiocchi C
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G786-801. PubMed ID: 22878121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
    Rieder F; Fiocchi C; Rogler G
    Gastroenterology; 2017 Feb; 152(2):340-350.e6. PubMed ID: 27720839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-
    Haring E; Zeiser R; Apostolova P
    Front Immunol; 2021; 12():705342. PubMed ID: 34249014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and Molecular Mediators of Intestinal Fibrosis.
    Lawrance IC; Rogler G; Bamias G; Breynaert C; Florholmen J; Pellino G; Reif S; Speca S; Latella G
    J Crohns Colitis; 2017 Dec; 11(12):1491-1503. PubMed ID: 25306501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science.
    Rieder F; Fiocchi C
    Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokine and immune responses in intestinal fibrosis.
    Yang B; Zhang G; Elias M; Zhu Y; Wang J
    J Dig Dis; 2020 Jun; 21(6):308-314. PubMed ID: 32410365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary salt exacerbates intestinal fibrosis in chronic TNBS colitis via fibroblasts activation.
    Amamou A; Rouland M; Yaker L; Goichon A; Guérin C; Aziz M; Savoye G; Marion-Letellier R
    Sci Rep; 2021 Jul; 11(1):15055. PubMed ID: 34301970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal Cell Regulation of Intestinal Inflammatory Fibrosis.
    Yang W; Yu T; Cong Y
    Cell Mol Gastroenterol Hepatol; 2024; 17(5):703-711. PubMed ID: 38246590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.